• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY SYNERGY¿; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number H7493926220220
Device Problems Device Or Device Fragments Location Unknown (2590); Device Dislodged or Dislocated (2923)
Patient Problem Device Embedded In Tissue or Plaque (3165)
Event Date 11/24/2016
Event Type  Injury  
Manufacturer Narrative
Age at the time of event: 18 years or older.Device is a combination product.(b)(4).Device evaluated by mfr: it is indicated that the device will not be returned for evaluation.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further relevant information from that review, a supplemental medwatch will be filed.(b)(4).
 
Event Description
It was reported that stent dislodgement occurred.Vascular access was obtained via the femoral artery.The totally occluded, concentric target lesion was located in the severely tortuous and severely calcified left anterior descending (lad) artery to the first diagonal artery.After pre-dilation was done, stent implantation was performed in the lad.Then a 2.25x20 synergy¿ drug-eluting stent was advanced and resistance was felt while trying to cross the previously placed stent and the lesion in the first diagonal artery.The stent was stripped off from the stent delivery system balloon.The stent was presumed to be in the lad.Post-dilation with a balloon catheter and "crushing" was performed in an effort to secure the stent.The procedure was completed with a different device.The patient was given the maximum dose of anticoagulation medication and remained under observation.No patient complications were reported and the patient¿s status was stable.
 
Manufacturer Narrative
(b)(4).
 
Event Description
It was further reported that the stent could not be located after it dislodged.The physician only presumes that the stent was crushed into the artery wall with another stent.There was no attempt to snare or retrieve the stent as it could not be seen.Final angiogram results were excellent.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY¿
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
Manufacturer (Section G)
BOSTON SCIENTIFIC - GALWAY
Manufacturer Contact
sonali arangil
one scimed place
maple grove, MN 55311
7634941700
MDR Report Key6182762
MDR Text Key62670707
Report Number2134265-2016-11511
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeAU
PMA/PMN Number
SIMILAR
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 11/24/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received12/16/2016
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date12/19/2017
Device Model NumberH7493926220220
Device Catalogue Number39262-2022
Device Lot Number0019439222
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/22/2017
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/15/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-